Journal
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
Volume 1867, Issue 5, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.bbadis.2021.166098
Keywords
Astrocyte; Gap junctions; Connexins; Hemichannels; CNS drugs; Neuropsychiatric diseases; Neurodegenerative diseases; Connexin-modulating drugs
Ask authors/readers for more resources
Astrocytes play a crucial role in the central nervous system through gap junctions formed by connexins, influencing neurodegenerative diseases and pharmacological profiles of CNS drugs. Modulation of astrocytic connexins represents an innovative approach for CNS disorders and offers new therapeutic perspectives.
Astrocytes represent the reticular part of the central nervous system; gap junctions formed by connexins Cx43, Cx30- and Cx26 provide for homocellular astrocyte-astrocyte coupling, whereas connexins Cx30, Cx32, Cx43, and Cx47 connect astrocytes and oligodendrocytes. Astroglial networks are anatomically and functionally segregated being homologous to neuronal ensembles. Connexons, gap junctions and hemichannels (unpaired connexons) are affected in various neuropathologies from neuropsychiatric to neurodegenerative diseases. Manipulation of astrocytic connexins modulates the size and outreach of astroglial syncytia thus affecting astroglial homeostatic support. Modulation of astrocytic connexin significantly modifies pharmacological profile of many CNS drugs, which represents an innovative therapeutic approach for CNS disorders; this approach is now actively tested in pre-clinical and clinical studies. Wide combination of connexin modulators with CNS drugs open new promising perspectives for fundamental studies and therapeutic strategies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available